Skip to Content

China Health Industries Holdings Inc CHHE

Morningstar Rating
$0.46 −0.57 (55.31%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CHHE is trading within a range we consider fairly valued.
Price
$0.46
Fair Value
$3.95
Uncertainty
Extreme
1-Star Price
$6.78
5-Star Price
$6.00
Economic Moat
Jjzr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CHHE is a good fit for your portfolio.

Trading Information

Previous Close Price
$1.03
Day Range
$0.460.65
52-Week Range
$0.104.15
Bid/Ask
$0.28 / $1.28
Market Cap
$30.17 Mil
Volume/Avg
6,100 / 5,293

Key Statistics

Price/Earnings (Normalized)
Price/Sales
314.41
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
34

Valuation

Metric
CHHE
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
314.41
Price/Cash Flow
Price/Earnings
CHHE

Financial Strength

Metric
CHHE
Quick Ratio
0.00
Current Ratio
0.04
Interest Coverage
Quick Ratio
CHHE

Profitability

Metric
CHHE
Return on Assets (Normalized)
−4.64%
Return on Equity (Normalized)
−5.92%
Return on Invested Capital (Normalized)
−4.88%
Return on Assets
CHHE
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
GbfscsspLqnnv$81.5 Bil
Merck KGaA ADR
MKKGY
QqnnktnthDcxmw$70.9 Bil
Haleon PLC ADR
HLN
XbqvcdcwPlrdk$40.1 Bil
Viatris Inc
VTRS
KhyrsgwVkh$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
CykyhmlwCsr$13.2 Bil
Catalent Inc
CTLT
WzwgzxctTxtgslb$10.5 Bil
Perrigo Co PLC
PRGO
XmgbmqpkRthtp$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
BdhcpwnpQlfcbv$3.5 Bil
Curaleaf Holdings Inc
CURLF
KkpptnsjjWtvv$3.1 Bil
Green Thumb Industries Inc
GTBIF
QpnwjzszHgh$2.6 Bil

Sponsor Center